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Abstract
Triosephosphate isomerase (TPI) deficiency is a poorly understood disease characterized
by hemolytic anemia, cardiomyopathy, neurologic dysfunction, and early death. TPI defi-
ciency is one of a group of diseases known as glycolytic enzymopathies, but is unique for its
severe patient neuropathology and early mortality. The disease is caused by missense
mutations and dysfunction in the glycolytic enzyme, TPI. Previous studies have detailed
structural and catalytic changes elicited by disease-associated TPI substitutions, and sam-
ples of patient erythrocytes have yielded insight into patient hemolytic anemia; however, the
neuropathophysiology of this disease remains a mystery. This study combines structural,
biochemical, and genetic approaches to demonstrate that perturbations of the TPI dimer
interface are sufficient to elicit TPI deficiency neuropathogenesis. The present study dem-
onstrates that neurologic dysfunction resulting from TPI deficiency is characterized by syn-
aptic vesicle dysfunction, and can be attenuated with catalytically inactive TPI. Collectively,
our findings are the first to identify, to our knowledge, a functional synaptic defect in TPI defi-
ciency derived from molecular changes in the TPI dimer interface.
Author Summary
Glycolysis is the metabolic pathway that cells use to break down the sugar glucose, and
mutations in the genes that control the glycolytic pathway elicit a collection of diseases
known as glycolytic enzymopathies. Glycolytic enzymopathies are rare genetic diseases
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that lead to the degeneration of patient red blood cells. Triosephosphate isomerase is a gene
that encodes a part of this glycolytic process, and patients with mutations in this gene
experience the typical blood disorder, as well as severe neurologic dysfunction and often
infant death. Until now, a molecular source of neurologic dysfunction in triosephosphate
isomerasemutants was unknown. We have discovered that mutations that disrupt the self-
association of the triosephosphate isomerase enzyme lead to neurologic dysfunction in
fruit flies. This neurologic dysfunction is characterized by the abnormal cycling of neuro-
nal vesicles that contain neurotransmitters. Given the evolutionary conservation of triose-
phosphate isomerase and neuronal synaptic function, we believe that these observations
represent the dysfunction seen in human patients.
Introduction
Triosephosphate isomerase (TPI) is a glycolytic enzyme that converts dihydroxyacetone phos-
phate (DHAP) into glyceraldehyde-3 phosphate (GAP). TPI is a non-linear member of the gly-
colytic pathway, enhancing the efficiency of the catabolic process, and several missense
mutations within TPI lead to a disease known as TPI deficiency [1]. TPI deficiency is one mem-
ber of a group of disorders caused by mutations in glycolytic enzymes, collectively called glyco-
lytic enzymopathies. Glycolytic enzymopathies are largely characterized as blood disorders,
with all patients experiencing hemolytic anemia [2,3]. TPI deficiency is one of the few glyco-
lytic diseases associated with patient neurologic dysfunction, and by far the most severe [1,4].
Clinical examinations of TPI deficiency patients have established that this disease is often char-
acterized by episodic seizures, periodic dystonia, and progressive weakness and flaccidity in
extremities [5–11]. Cellular studies have centered on erythrocytes and lymphocytes, leaving it
unclear how TPI molecular dysfunction influences the nervous system. Further, the absence of
neurologic dysfunction in many other glycolytic enzymopathies has made it unclear whether
these symptoms are related to glycolysis or an as-yet-unidentified function of TPI.
Several reports have suggested that TPI deficiency is a disease caused by changes in protein
conformation rather than metabolic defects [4,12–14]. A human protein structure and yeast
genetic studies have asserted that defects in TPI dimerization are the primary determinants of
pathology [15,16], revealing no catalytic defects in vitro or from cell lysate. However, not all
TPI deficiency mutations lack catalytic defects. An erythrocyte study examining two Hungar-
ian brothers with identical TPI alleles revealed equivalent reductions in TPI activity in both
individuals [17], yet one exhibited severe neurologic dysfunction and the other was asymptom-
atic. Further, a recent structural study demonstrated that the hTPII170V substitution signifi-
cantly altered enzyme kinetics and protein stability through a molecular alteration near the
catalytic pocket [18]. Collectively, each of these studies failed to establish a causal relationship
between TPI activity and disease.
Previously, a pathogenic substitution in Drosophila TPI (dTPIM80T) was identified, eliciting
mechanical- and thermal-stress dependent paralysis [19,20]. These behavioral phenotypes
have been independently established as hallmarks of neurologic dysfunction and each has been
used in forward genetic screens to identify novel components of neuronal transmission [21–
23]. The dTPIM80T allele was identified in such a screen [20,24], and to-date D.melanogaster is
the only model organism to exhibit neurologic dysfunction caused by TPI deficiency. The
dTPIM80T protein was found to be prematurely degraded with reduced catalytic activity
[25,26]. This reduction in catalytic activity was shown to inhibit glycolytic flux as well as induce
metabolic stress [19,25], yet did not change ATP levels in vivo [20]. Subsequent studies
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demonstrated that the dTPIM80T point mutation could be complemented by the addition of a
catalytically inactive TPI without increasing lysate isomerase activity or alleviating metabolic
stress [25], suggesting that dTPIM80T may elicit pathology through a change in protein confor-
mation. Thus, we initially examined the molecular source of dTPIM80T pathology.
To determine whether Drosophila TPI deficiency was caused by changes in protein confor-
mation, we purified and assessed the physical characteristics of hTPIM82T, the human equiva-
lent of dTPIM80T, and revealed impaired TPI dimerization. These results were further
supported when independent alleles bearing mutations at the TPI dimer interface phenocopied
the Drosophila behavioral dysfunction seen in the dTPIM80T allele. These experiments provided
novel insight into the pathogenesis of TPI deficiency leading to the conclusion that alterations
of TPI dimerization are sufficient to elicit neuropathology.
Defining the molecular source of TPI neurologic dysfunction led to the generation of new
alleles containing dimer-interface mutations. These novel TPI alleles were characterized by
extreme behavioral defects, directing new investigations into the neuropathogenic mechanism
of TPI deficiency. An examination of vesicle dynamics at the larval neuromuscular junction
(NMJ) revealed a severe impairment that appears to be related to vesicle recycling. Further,
complementation with a TPI allele encoding catalytically inactive TPI rescued both synaptic
dysfunction and behavior, thereby characterizing a cellular mechanism of TPI deficiency
neuropathology.
Collectively, the results of this study support the conclusion that an improperly formed
dimer interface is sufficient to elicit TPI deficiency neuropathology. Further, our experiments
establish that a functional synaptic defect occurs in our Drosophilamodel of TPI deficiency.
Results
hTPIM82T impairs TPI homodimerization
TPI is a homodimeric enzyme with catalytic sites in the C-terminal of a triose isomerase (TIM)
barrel tertiary structural motif [27]. Each catalytic site is rigidified through dimerization to
increase catalytic turnover, yet each active site works independently [28–30]. A dTPIM80T sub-
stitution was previously isolated and demonstrated to elicit pathology in a Drosophilamodel of
TPI deficiency [19,20]. The dTPIM80T substitution is physically located in a solvent-exposed
region of the protein near the dimer interface [25]. Numerous misfolding events could be
hypothesized to occur as a function of the TPIM80T substitution, among them alterations of
dimerization [15,16] and aggregation [31]. To examine the structural change elicited by M80T
in vitro we purified Drosophila dTPIM80T.
Previous purification experiments had yielded Drosophila TPI enzyme, but these samples
proved aggregation prone at high concentrations. Conversely, purified human TPI (hTPI) was
well-behaved; therefore, in order to physically characterize TPI we studied the human protein
in vitro. To validate the use of human protein in vivo we generated humanWT (hTPIWT) and
human M80T (hTPIM82T) alleles in the Drosophila TPI gene locus using an established genomic
engineering (GE) system [25]; the hTPIM82T substitution is equivalent to dTPIM80T (Fig 1A).
We found that hTPIM82T was able to recapitulate the disease phenotypes observed in dTPIM80T
(S1 Fig). The phenotypes of hTPIM82T were remarkably similar but less severe than dTPIM80T,
possibly due to subtle organism-specific changes in the dimer interface [32]. Confirmation that
hTPIM82T pathologically phenocopied dTPIM80T indicated that any conformational change elic-
ited by dTPIM80T was likely retained in the human protein.
We utilized dynamic light scattering (DLS) to examine potential conformational differences
between hTPIWT and hTPIM82T. Analyses of 15 μM solutions of hTPIWT revealed a hydrody-
namic radius of 4.3±0.08 nm, while hTPIM82T exhibited a significant reduction to 3.3±0.06 nm
Neurologic Dysfunction in TPI Deficiency
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Fig 1. hTPIM82T elicits a conformational change in TPI resulting in reduced dimerization. (A) Sequence alignment of D.melanogaster andH.sapiens TPI
protein sequence with asterisks highlighting residues of interest. (B) The hTPIM82T mutation confers a reduction in mean protein hydrodynamic radius as
measured by dynamic light scattering. (C) Intensity correlation plots reveal a largely monodisperse hTPIWT population and polydisperse hTPIM82T population.
(D) Gel filtration indicates a change in monomer:dimer ratios elicited by hTPIM82T with relative quantification (inset). n3, comparisons were made using
Student’s T test, *** indicates p<0.001.
doi:10.1371/journal.pgen.1005941.g001
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(Fig 1B); these results were consistent across two additional protein concentrations, 3.75 μM
and 30 μM (Fig 1B). The linear slope generated by plotting the intensity correlation data sug-
gested the hTPIWT sample was largely monodispersed, much like that of the 15 μM sample of
bovine serum albumin (Fig 1C). Conversely, hTPIM82T samples exhibited a non-linear slope
(Fig 1C), suggesting the possibility of a polydisperse protein population. Polydisperse protein
populations indicated the sample was a mixed population in solution, and the observed reduc-
tion in TPI mean hydrodynamic radius suggested the sample could be a mixture of monomer
and dimer TPI species.
We examined enzyme dimerization by assessing protein size via gel filtration chromatogra-
phy. A standard curve was used to establish column resolution, 15 μM samples of hTPIWT and
hTPIM82T were injected onto the gel filtration column, and their migration monitored by UV
light at 280 nm. hTPIWT samples separated into two distinct peaks–one at ~24 min. and
another at ~27 min. corresponding to ~50 kDa and ~28 kDa, respectively (Fig 1D). Dimeric
and monomeric hTPI are 54 and 27 kDa, respectively. Integrating the peak areas revealed an
~80:20 split in dimer:monomer ratio of hTPIWT (Fig 1D inset). In contrast, the majority of the
hTPIM82T sample eluted at 27 min., resulting in a ~5:95 dimer:monomer ratio (Fig 1D inset).
These data led us to conclude that the hTPIM82T substitution elicited a dramatic conforma-
tional change in TPI resulting in a disruption of dimerization. Interestingly, the gel filtration
results did not precisely reflect the monodisperse vs. polydisperse observations of the DLS
experiments; we believe this could be due to dilution effects as the proteins migrated over the
large gel filtration column.
TPI dimer interface mutants recapitulate dTPIM80T neuropathology
Having established that the hTPIM82T mutation alters enzyme dimerization in vitro, we sought
to assess whether other substitutions at the TPI dimer interface were sufficient to elicit neuro-
pathology. Two novel TPI alleles (dTPIT73R and dTPIG74E) were generated using GE. Our hTPI
dimer analyses (S2 Fig) and data from previous TPI studies [28] indicated these substitutions
would result in dimer defective TPI. dTPIT73R and dTPIG74E dimer interface mutants elicited a
more severe pathology than dTPIM80T, and stocks required maintenance over balancer chro-
mosomes due to their poor viability. Test crosses of balanced stocks yielded significantly fewer
homozygous animals than the Mendelian predicted 33%, and homozygous animals were
extremely short-lived (Fig 2A), with median lifespans of 2 and 5 days for dTPIT73R and
dTPIG74E, respectively.
Mechanical- and thermal stress-dependent behavioral defects were assessed at Day 1 and
Day 2, respectively, as these phenotypes have been demonstrated to be hallmarks of Drosophila
TPI deficiency [19,20,25,26,33,34]. dTPIM80T was previously described to exhibit a modest phe-
notype at early time points [19], and these data corroborate our analyses of the GE dTPIM80T
allele (Fig 2B and 2C). Comparatively, the dimer interface mutants displayed a more severe
degree of behavioral dysfunction than that seen in dTPIM80T (Fig 2B and 2C). These data sup-
port the hypothesis that mutations at the dimer interface are sufficient to induce neurologic
dysfunction.
Lysate isomerase activity was compared between samples taken from animals homozygous
for the dimer interface mutants. First, it was noted that all dimer interface mutants exhibited
reductions in TPI activity (Fig 2D). However, a comparison of the dTPIM80T, dTPIT73R, and
dTPIG74E lysates revealed a striking observation–the least phenotypically severe mutation
(dTPIM80T) was characterized by the lowest isomerase activity (Fig 2D). These data support
previous observations that TPI activity does not predict the presence or severity of TPI defi-
ciency [25].
Neurologic Dysfunction in TPI Deficiency
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Many conformational diseases are elicited through changes in protein structure and stability
leading to misfolding, then either sequestration and degradation, or aggregation [35]. First, we
examined whether these new dimer interface alleles produced robust levels of TPI protein. We
determined TPI levels in our dimer interface mutants as previously [34], and found that both
dTPIT73R and dTPIG74E homozygotes exhibited reduced protein levels (Fig 3A and 3B).
It has previously been shown that TPI has the capacity to aggregate and thereby seed the
aggregation of other proteins such as tau [31]. When measuring protein levels via SDS-PAGE,
it is important to note that not all aggregate species are SDS soluble and a reduction in protein
levels can indicate that the aggregates are not passing through the gel matrix. To determine
whether the dTPIT73R and dTPIG74E proteins aggregate we used a dot-blot filter trap assay to
assess retention differences between TPI mutant isoforms, as performed previously [36].
Lysates were collected from homozygous animals, and PC12 cell lysates expressing EGFP-hun-
tingtin-Q97 (GFP htt-Q97) were used as a positive aggregation control. The results indicate
that little TPI was trapped on the 200 nm filter, yet each sample showed a concentration-
dependent increase in signal (Fig 3C). Importantly, no differences were observed in TPI signal
between the WT and mutant alleles (Fig 3C). These data support similar findings established
by sedimentation assays performed on dTPIM80T [34], and led us to conclude that although
these dimer interface mutants display reduced protein levels via SDS-PAGE, this is not due to
the insolubility of large aggregates.
To date, all but one study examining TPI deficiency in Drosophila have highlighted a reduc-
tion in TPI protein levels in disease-associated alleles [18–20,25,26]. To independently examine
Fig 2. Mutations affecting the TPI dimer interface recapitulate dTPIM80T phenotypes. (A) dTPIT73R and dTPIG74E homozygotes display severely reduced
lifespans, n>150. (B) Dimer interface mutations exhibit severe mechanical stress at Day 1 and (C) thermal stress sensitivity at Day 2, n>30. Thermal stress
paralysis times at 360 sec. represent wild type behavior, the assay was stopped at 6 min. (D) Both dTPIT73R and dTPIG74E homozygotes display reduced
lysate isomerase activity, n3. Comparisons were made with a One-way ANOVA using Tukey’s post hoc test, and lifespans by a Log-rank (Mantel-Cox)
survival test, ** indicated p<0.01, *** p<0.001.
doi:10.1371/journal.pgen.1005941.g002
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the importance of TPI protein levels in vivo, we employed the GAL4-UAS expression system to
knock down wild type (WT) TPI using a UAS-RNAi line directed toward dTPImessenger
RNA (mRNA) [37]. These lines were driven with actin-GAL4 + UAS-GAL4 (actin/UAS--
GAL4) to obtain a dramatic reduction of TPI in all tissues.
Using UAS-RNAi in conjunction with actin/UAS-GAL4, we found that w;actin-GAL4,
UAS-GAL4/+;UAS-RNAiTPI/+ animals exhibited a dramatic reduction in TPI protein levels
similar to that seen in head and thorax tissue from w;;dTPIM80T homozygotes (S3A and S3B
Fig). Head and body tissues were assessed separately to ensure equivalent knockdown in both
tissues. Next, we examined animal behavior in these knockdown populations to determine
whether depletion of cellular TPI was sufficient to elicit TPI deficiency behavioral abnormali-
ties. Mechanical stress responses were used to quantify behavioral dysfunction. None of the
knockdown genotypes exhibited abnormal mechanical-stress dependent responses (S3C Fig).
No paralysis or seizure-like activity was observed in the knockdown genotypes at elevated tem-
peratures, though hypoactivity was noted, with the knockdown animals consistently dwelling
near the bottom of the vial relative to their TPI+ and UAS only controls. These observations
suggested that a general depletion of TPI is not sufficient to elicit paralysis or seizure-like loco-
motor dysfunction, yet do not exclude the possibility that changes in protein conformation,
localized subcellular depletions, or changes in protein stability may play a greater role in animal
pathology.
A catalytically inactive TPI enzyme suppresses TPI deficiency
Previous work demonstrated that a catalytically inactive allele of TPI (dTPIΔcat) complemented
the behavior and longevity defects of the dTPIM80T allele [25], a mutation now established to
disrupt enzyme dimerization. This previous study suggested that TPI deficiency is a loss-of-
function disease caused by either i) the depletion of cellular TPI, or ii) a conformational change
that could be rescued through the addition of a properly folded yet catalytically open/inactive
Fig 3. Mutations at the TPI dimer interface reduce TPI levels in vivowithout aggregation. (A) dTPIT73R and dTPIG74E homozygote animal lysates display
reduced protein levels with (B) quantification normalized to WT and an ATPalpha loading control, n = 3. (C) The reduction in SDS-soluble TPI is not caused
by protein aggregation; increasing amounts of lysate were loaded and show no differences in filter-trapped TPI across all genotypes, (D) 10μg of huntingtin
exon1-GFP lysate displayed robust retention on the filter, n = 2. Comparisons were made with a One-way ANOVA using Tukey’s post hoc test, *** p<0.001
relative to WT.
doi:10.1371/journal.pgen.1005941.g003
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isoform [25]. Having utilized knockdown strategies to examine the necessity of total TPI levels,
we sought to confirm the capacity of dTPIΔcat (Lys-to-Met, position 11, Fig 1A) to complement
additional dimer-interface mutations. To evaluate whether dTPIΔcat was sufficient to support
normal behavior and longevity, dTPI+/dTPI+, dTPI+/dTPIT73R, dTPIT73R/dTPIT73R, dTPIT73R/
dTPIΔcat, dTPI+/dTPIG74E, dTPIG74E/dTPIG74E, and dTPIG74E/dTPIΔcat animals were collected
and tested as outlined above. These experiments demonstrated that the dTPIT73R allele was
nearly fully complemented by dTPIΔcat (Fig 4A–4C), similar to the results found with dTPIM80T
[25]. It should be noted that this complementation was not fully penetrant; 5 out of the 30
dTPIT73R/dTPIΔcat animals did paralyze after an extended thermal stress period (Fig 4B). The
penetrance of the thermal stress complementation is reflected in an increased time to paralysis
relative to the homozygous mutant animals (Fig 4B and 4E). dTPIG74E was also complemented
by dTPIΔcat, although more modestly than was observed for dTPIT73R. Mechanical stress
responses were unchanged in dTPIG74E/dTPIΔcat relative to dTPIG74E homozygotes, though the
penetrance of thermal stress sensitivity was decreased to 20 out of 30 animals, and the median
lifespan of the dTPIG74E mutants was extended from 5 to 21 days (Fig 4D–4F). Importantly,
neither of the dimer interface mutants elicited dominant negative effects within the dTPI+ het-
erozygotes; to the contrary, dTPIT73R and dTPIG74E promoted a significant increase in animal
health, extending the median 48 day dTPI+/dTPI+ lifespans to 77 and 71 days, respectively (Fig
4C and 4F). In toto, dTPIΔcat partially but significantly complemented each of the new TPI
dimer alleles.
Fig 4. A catalytically inactive allele attenuates TPI dimer mutant behavior and longevity. (A) dTPIΔcat complements dTPIT73Rmechanical and (B)
thermal stress sensitivity and (C) longevity, and (D,E) partially attenuates behavior and (F) longevity defects of dTPIG74E. Thermal stress paralysis times at
360 sec. represent wild type behavior, the assay was stopped at 6 min. n30 for behavior, and n90 for lifespans. Behavior was compared using a One-way
ANOVA with Tukey’s post hoc test, and lifespans by a Log-rank (Mantel-Cox) survival test, ns indicates no significance, and *** p<0.001.
doi:10.1371/journal.pgen.1005941.g004
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hTPIΔcat crystal structure
Our experiments with TPI dimer mutations demonstrated that alterations of the dimer inter-
face were sufficient to elicit TPI neurologic dysfunction, and that these phenotypes were able to
be complemented with dTPIΔcat. To address how the TPIΔcat substitution may influence its
structure, we purified, crystallized, and determined the structure of hTPIΔcat at 1.7Å resolution,
refining against native data to Rwork and Rfree values of 15.8%, and 19.6%, respectively
(Table 1). These crystals grew in conditions that were nearly identical to conditions in which
we have previously determined the structure of wild-type human TPI [18], minimizing the
effects that changes in the crystallization condition or crystal packing might have on the result-
ing structure. While the overall fold of hTPIΔcat is highly similar to wild-type (r.m.s.d of 0.35 Å
over all atoms) there are a number of important differences within the catalytic pocket and
neighboring regions. First, the active site pocket of our previous hTPIWT structure contained a
Table 1. Crystallographic Data collection and Refinement statistics.
hTPIΔCAT
Data collection
Space group P 212121
Wavelength (Å)
Cell dimensions
a, b, c (Å) 65.1, 73.5, 92.8
α, β, γ (°) 90.0, 90.0, 90.0
Unique Reﬂections 48,935
Resolution (Å) 50.0–1.70 (1.73–1.70)
Rmerge (%) 6.3 (58.6)
I / σI 42.0 (2.9)
Completeness (%) 100 (100)
Redundancy 12.3 (11.2)
Reﬁnement
Resolution (Å) 48.7–1.70 (1.73–1.70)
Rwork / Rfree (%) 15.8/19.6 (21.0/29.4)
FOM 0.87 (0.82)
Number of. atoms
Protein 7,432
Other 16
Solvent 455
B-factors
Protein 30.6
Other 54.1
Solvent 37.8
R.m.s. deviations
Bond lengths (Å) 0.017
Bond angles (°) 1.25
Rotamer outliers (%) 1.81
Ramachandrian
Outliers (%) 0.20
Allowed (%) 1.43
Favored (%) 98.4
*Values in parentheses are for highest-resolution shell.
doi:10.1371/journal.pgen.1005941.t001
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highly ordered phosphate and bromide ion located where the phosphate and triose groups of
the natural substrate, DHAP, would be located [18]. In contrast, the active site pocket of hTPIΔ-
cat was filled with solvent. At the site of the hTPIK13M substitution (hTPIΔcat), the M13 side
chain adopts a different conformation than its lysine counterpart, shifting 4 Å away from the
catalytic site and interacting with N11, G233 and L236 at the back of the pocket (Fig 5A). The
sidechain positions of important active site residues S96 and E165 are also altered in hTPIΔcat,
breaking critical solvent networks and shifting E165 2.7 Å away from the position it adopts in
wild-type TPI [18] and substrate analog bound structures [38–40] (Fig 5A). Lastly, the lid
moves as much as 7 Å away from the active site pocket, adopting an open conformation
[40,41] (Fig 5A) and corroborating established kinetic data demonstrating that this enzyme is
catalytically inactive [42]. These data are in agreement with a structure of yeast TPIK12M,G15A
containing two mutations within the active site [43], but were an important control to isolate
the structural impact of hTPIK13M. Importantly, examinations of the dimer interface of hTPIΔ-
cat revealed that it is unchanged relative to hTPIWT (Fig 5B). The peptide backbone and side
chains of Loop3 form the majority of the TPI dimer interface, and as shown previously, pertur-
bations of this loop disrupt TPI dimer stability [28–30,44]. The new crystal structure revealed
that the backbone of Loop3 along with important side chains M14, T75, G76, M82, and E104,
are unaltered in hTPIΔcat (Fig 5B). These structural data indicated that TPIΔcat homodimers are
catalytically inactive, with no observable alterations of the overall folding of the monomers or
their dimeric assembly (Fig 5B).
dTPIΔcat forms heterodimers with mutant TPI subunits
Complementation of the TPI dimer mutant alleles with dTPIΔcat suggested a physical and/or
functional interaction between the two enzymes. Given the dimeric nature of TPI, we sought to
first examine physical interactions between TPI species. All of the dimer-interface substitutions
used in this study disrupt homodimerization (Figs 1 and S2), though no experiments had yet
addressed how these alterations may change heterodimerization with dTPIΔcat. These putative
heterodimers could support or inhibit a critical function of TPI.
To examine heterodimer formation in vivo, we measured the capacity of the dimer-mutant
TPI isoforms to co-precipitate using a C-terminal Cerulean cyan fluorescent protein (CFP)
tagged variant of dTPIΔcat-CFP; this allele was previously confirmed to complement dTPIM80T
Fig 5. hTPIΔcat crystal structure reveals a catalytically incompetent enzymewith an unaltered dimer interface. (A) The hTPIΔcat adopts an open lid
conformation. Superposition of hTPIWT (grey) and hTPIΔcat (blue) structures. Loop3 (tan), the position of the lid covering the TPI active site (magenta and
pink), and the locations of bromide and phosphate ions from the active site pocket of hTPIWT are indicated. New hydrophobic interactions that help to
reposition M13 are shown (green). (B) The dimer interface of hTPIΔcat is unchanged relative to hTPIWT. Superposition of hTPIWT (grey) and hTPIΔcat shown
as in (A), with monomer subunits of hTPIΔcat dimer in blue and tan. Key dimer interface residues and loops are indicated.
doi:10.1371/journal.pgen.1005941.g005
Neurologic Dysfunction in TPI Deficiency
PLOS Genetics | DOI:10.1371/journal.pgen.1005941 March 31, 2016 10 / 30
[25]. anti-GFP was covalently conjugated to the AminoLink resin, and the CFP tag was immu-
noprecipitated (IPed) in dTPIWT/dTPIΔcat-CFP, dTPIM80T/dTPIΔcat-CFP, dTPIT73R/dTPIΔcat-CFP,
and dTPIG74E/dTPIΔcat-CFP animal lysates and probed. Unconjugated resin was incubated with
dTPIWT/dTPIΔcat-CFP lysate and used as a negative control (-) (Fig 6A, IP). Upon elution and
SDS-PAGE separation, protein size was used to discriminate between the tagged and untagged
TPI isoforms; the CFP tag roughly doubled the molecular weight of dTPI-CFP monomer (~50
kDa) relative to dTPI monomer (~25kD) (Fig 6A, Input).
Robust amounts of dTPIWT precipitated with dTPIΔcat-CFP, establishing substantial hetero-
dimerization between the two species (Fig 6A and 6B) in agreement with the similarities
between their respective dimer interfaces (Fig 5B). Conversely, dTPIM80T and dTPIT73R dis-
played markedly reduced associations with dTPIΔcat-CFP, corroborating their previously estab-
lished dimerization deficiencies and reflecting their overall prevalence in the lysate (Fig 6A).
Finally, it was surprising to see that dTPIG74E produced heterodimerization similar to that seen
in dTPIWT (Fig 6A and 6B); it was predicted that the rotational flexibility of G74 was necessary
for the appropriate positioning of loop 3 and establishment/rigidification of the dimer interface
[28].
The coIP experiments suggested that the TPI species responsible for dTPIT73R phenotype
suppression in the animals was not a dTPIΔcat heterodimer; the heterodimer was a very small
fraction of the total TPI enzyme in lysate (Fig 6). Conversely, the dTPIΔcat-CFP::dTPIG74E het-
erodimer existed as a substantial fraction of the total TPI (Fig 6), yet exhibited modest comple-
mentation of the abnormal behavioral phenotypes (Fig 3). The substantial and unanticipated
presence of the dTPIΔcat-CFP::dTPIG74E heterodimer could indicate an allele-specific dominant
interaction. To examine whether we could enhance the capacity of dTPIΔcat to suppress
dTPIG74E, we designed a double-mutant aiming to revert heterodimer formation.
An allele was generated bearing both substitutions, dTPIT73R,G74E, and animals homozygous
for this allele displayed aggressive behavioral phenotypes and shortened lifespans (S4A, S4B
and S4D Fig). Immunoprecipitation experiments found that the double substitution reduced
dTPIT73R,G74E heterodimerization with dTPIΔcat-CFP relative to dTPIG74E (Fig 6). Finally, when
paired with the dTPIΔcat allele, the addition of the T73R substitution to dTPIG74E enhanced the
capacity for dTPIΔcat-behavioral complementation (S4A and S4B Fig). The mean time to
Fig 6. Heterodimerization of inactive TPI and dimer interfacemutations. (A) dTPIΔcat-CFP interacts modestly with dTPIM80T, dTPIT73R, and dTPIT73R,G74E,
yet robustly with dTPIG74E. Representative immunoprecipitation and input blots are shown with (B) IP:anti-GFP quantification n = 3. Quantification represents
25kD TPI IP signal, with negative control subtracted, normalized to the lysate β-tubulin loading control, and compared to WT. Comparisons were made with a
One-way ANOVA using Tukey’s post hoc test, ns indicates no significance, ** p<0.01, and *** p<0.001.
doi:10.1371/journal.pgen.1005941.g006
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recovery after mechanical stress was reduced from 204 sec. in dTPIT73R,G74E homozygotes to 50
sec. in dTPIT73R,G74E/dTPIΔcat animals with approximately 60% of the animals no longer
responding to the stressor (defined as a recovery time 5 sec.) (S4A Fig); similar complemen-
tation was observed in the thermal stress assay (S4B Fig). Curiously, the longevity of the
dTPIT73R,G74E/dTPIΔcat animals was unchanged relative to dTPIT73R,G74E homozygotes (S4D
Fig); this is the second time that TPI deficiency behavioral abnormalities and longevity have
not paralleled each other [18], suggesting the possibility of independent pathogenic mecha-
nisms (see Discussion).
The inverse correlation between dTPIΔcat heterodimerization and behavioral complementa-
tion suggested that dTPIΔcat did not complement TPI deficiency behavioral phenotypes via het-
erodimer formation. Further, disease severity did not correlate with isomerase activity (S5B
Fig); complementation of the dimer-mutant alleles with dTPIΔcat failed to increase isomerase
activity and in all but one case significantly decreased activity (S4C and S5 Figs). These data led
us to conclude that dTPIΔcat does not “suppress” TPI deficiency behavioral phenotypes through
a general influence on TPI catalytic activity.
Severe TPI dimer impairment alters synaptic function
TPI deficiency complementation was not corroborated by an enhancement of TPI catalysis;
however, the mean temperature-dependent time to paralysis of the dTPIT73R allele (27 sec) was
a striking result (Fig 2B) and suggested a previously unknown role of TPI. Rapid (<60 sec.)
temperature-dependent paralysis had only been identified in a handful of mutants in Drosoph-
ila and typically results from neural conductance or synaptic vesicle recycling defects [45]. To
determine whether TPI was influencing vesicle dynamics, we first examined vesicle endocytosis
at the synapse using the lipophilic dye, FM1-43. FM1-43 is a water soluble membrane dye that
increases its fluorescence when bound to cellular membranes. During endocytosis, the dye will
bind to the outer leaflet of the plasma membrane and become internalized within the synapse
providing an optical measurement of endocytosis. Measuring vesicle dynamics in this context
allowed us to assess two possibilities; i) a primary recycling defect due to impaired endocytosis,
or ii) a secondary recycling defect due to aberrant exocytosis.
We dissected larvae homozygous for dTPIWT, dTPIT73R, and Shits1 as previously detailed
[46]. The NMJ preparations were heated to 38°C over 3 min. and a loading curve was generated
from a series of three different high [K+] + FM1-43 loading times– 15 sec., 30 sec., and 60 sec.
as previously detailed [47]. dTPIWT displays a progressive increase in dye loading from 15 sec.
to 60 sec. (Fig 7A), while the temperature sensitive dynamin mutant control Shits1 showed no
signs of vesicle recycling at any heated time points (Fig 7D, data not quantified). Conversely,
although dTPIT73R displayed similar loading to dTPIWT at 15 and 30 sec., dTPIT73R exhibited a
striking 50% decrease in loading at 60 sec. (Fig 7A, 7B and 7D). This progressive decrease in
endocytosis was stimulation and temperature dependent; loading experiments performed at
room temperature did not exhibit an endocytic defect (Fig 7C). As previous experiments had
highlighted the capacity of dTPIΔcat to complement the adult behavioral defects of dTPIT73R,
we examined dTPIT73R/dTPIΔcat larvae to assess the relationship between vesicle endocytosis
and animal behavior. The dTPIT73R/dTPIΔcat animals displayed a significant increase in vesicle
endocytosis relative to dTPIT73R (Fig 7B and 7D). These results demonstrate that dTPIΔcat com-
plements adult behavior and vesicle endocytosis defects. The utilization of chemical stimula-
tion in these preparations demonstrates a synaptic defect arising from the severe dTPIT73R
dimer mutation as this methodology bypasses conductance requirements.
A reduction in vesicle dye uptake could be derived from defects in endocytosis or exocytosis,
and indeed, these activities are intimately linked [48]. To examine temperature-dependent
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changes in vesicle fusion, dTPIWT and dTPIT73R animals were i) loaded with dye at RT for 3
min., ii) washed with 0 mM Ca2+ HL-3, iii) imaged, iv) heated to 38°C, v) vesicle fusion initi-
ated with 30 sec. of high [K+] HL-3, and vi) reimaged. Care was taken to ensure the same syn-
apses were imaged at loading and unloading timepoints. Preliminary experiments
demonstrated that 60 sec. of high [K+] stimulation completely unloaded the synapses in each
genotype; therefore 30 sec. was analyzed to achieve a measurable dynamic range. Unloading
experiments at elevated temperatures demonstrated no change in vesicle exocytosis between
dTPIWT and dTPIT73R at 38°C (Fig 7E and 7F).
Finally, functional changes at the synapse can be the result of acute impairments in recycling
machinery or more chronic developmental defects. Mutations in the E3- ubiquitin ligase High-
wire or alterations in the trans-synaptic signaling proteins wingless and Glass-bottom boat have
been shown to alter synaptic function through primary changes in development [49–51].
These changes in synaptic physiology are accompanied by dramatic alterations in synaptic
morphology, a hallmark of neurodevelopmental defects. To examine whether aberrant neuro-
development may contribute to this recycling deficit, we morphologically characterized the
Fig 7. dTPIT73R impairs NMJ synaptic vesicle dynamics. (A) An FM1-43 timecourse at the NMJ with loading times of 15, 30, and 60 sec., (B) with
quantification of 60 sec. at 38°C, and (C) 60 sec. at room temperature (RT). (D) Representative images of dTPIWT, dTPIT73R, dTPIT73R/Δcat and Shits1, n = 6.
(E) FM1-43 unloading is unchanged between dTPIWT and dTPIT73R at 38°C with animal replicates indicated, and (F) representative images. Comparisons
were made with a One-way ANOVA using Tukey’s post hoc test, ***p<0.001. Scale bars = 5μm.
doi:10.1371/journal.pgen.1005941.g007
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Drosophila NMJ from segment A2, muscle 6/7; this particular NMJ is highly elaborate and
therefore sensitive to developmental perturbations. The dTPIM80T, dTPIT73R, and dTPIG74E
alleles all exhibited early lethality if maintained at 25°C, therefore development was scored at
RT. Third instar larva were dissected, and an assessment of bouton number and branches
revealed no significant developmental differences in the thermal-stress sensitive mutants rela-
tive to dTPIWT (Fig 8). These results suggest that the synaptic defect is an acute disruption of
function, and not likely a secondary defect caused by altered development. Collectively, these
data demonstrate that TPI deficiency thermal-stress sensitivity is characterized by acute pertur-
bation of synaptic vesicle dynamics.
Discussion
We conclude that the impairment of TPI dimerization is sufficient to elicit neurologic dysfunc-
tion. Dimerization of TPI is critical to its conformation, stability, and catalytic properties; and
disruption of these molecular properties impedes vesicle dynamics at the synapse. Impaired
synaptic function is thermal-stress dependent, and both vesicular and behavioral abnormalities
can be genetically complemented through a catalytically inactive TPI allele.
Triosephosphate isomerase dimerization
The pathogenic hTPIM80T substitution impairs TPI dimerization. These results were obtained
from purified proteins and do not corroborate those from non-denaturing gel filtration experi-
ments performed on animal lysates [26]. However, several in vitro studies have found that
mutations that impair TPI dimerization severely destabilize the protein [28,30,44,52,53]. In
vivo, unstable proteins are bound by chaperones and either refolded, targeted to the
Fig 8. TPI dimer interface substitutions do not alter NMJ development andmorphology. (A) NMJ morphology of segment A2 muscle 6/7 was
characterized for (B) bouton number and (C) branching. Boutons were defined as varicosities greater than 2 μm in diameter. Neither parameter showed
significant differences elicited by the mutations, relative to either dTPIWT or dTPIWT-CFP/TPIWT. CFP tags did not alter the behavioral deficits of the animals (S6
Fig). n = 10. Comparisons were made with a One-way ANOVA using Tukey’s post hoc test, ns indicated no significance. Scale bar = 10 μm.
doi:10.1371/journal.pgen.1005941.g008
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proteasome, or aggregate [54]. The results presented here suggest that dTPIM80T does not cause
TPI to aggregate (Fig 3), while previous work extensively details the recruitment of Hsp70 and
Hsp90 to dTPIM80T and its degradation through the proteasome [34]. Therefore, we hypothesize
that TPI monomer may not have been detected previously in animal lysates due to its rapid
sequestration and degradation. We believe these data, along with the previous inability to identify
monomer in vivo, collectively suggest that TPI does not stably exist in vivo as a soluble monomer.
We utilized our GE system to generate two additional TPI alleles with point mutations at
the dimer interface that have previously been shown to impair homodimerization [28]. These
substitutions were located at the tip of the 3rd loop of TPI that extends into its dimer partner
and stabilizes/rigidifies a network of hydrophobic interactions and hydrogen bonds which
form the dimer interface [28,29,55]. The substitution of these dimer interface residues resulted
in severely pathogenic TPI alleles, eliciting greater behavioral dysfunction and shorter lifespans
than dTPIM80T (Fig 2).
Molecular basis of TPI deficiency
A universal molecular mechanism of TPI deficiency pathogenesis is currently unclear. To date,
two crystal structures of disease-associated TPI mutations have been reported [15,18]. These
mutations were found in two distinct structural regions of the TPI homodimer. The first struc-
ture to be solved was from the most commonly diagnosed TPI deficiency substitution,
hTPIE104D [15]. The hTPIE104D substitution is a conservative alteration of a charged residue at
the dimer interface that results in reduced dimer stability, but unchanged catalytic activity
[15,16]. The second disease-associated structure was an hTPII170V substitution, a conservative
substitution found on the catalytic lid of the enzyme that enhances thermal stability and
reduces catalytic activity [16,18]. The dimer substitutions used in this study share several
molecular characteristics with the TPIE104D human mutation, and given the conservation of
the TPI enzyme, we propose that these patients likely share similar molecular and cellular dys-
function as identified in this study. Conversely, the dimer substitutions are not predicted to
share many molecular similarities with the hTPII170V mutation indicating that dimerization
defects are sufficient but not necessary to elicit TPI deficiency. It is interesting to note that
although dTPIT73R and hTPII170V both exhibit mechanical and thermal stress sensitivities in
Drosophila, the behavioral dysfunction caused by the dimer substitutions is far more severe,
and hTPII170V does not influence animal longevity [18]. Further, the capacity to attenuate
behavioral dysfunction but not longevity in dTPIT73R,G74E/dTPIΔcat suggests an independent
pathogenic mechanism (S4 Fig) that may not be determined by TPI dimerization.
TPI dimerization and protein stability in vivo will ultimately influence catalytic capacity,
and many TPI activity measurements from animal models and patient tissue samples have
identified a reduction in isomerase activity [7,14,17,18,25,56–58]. However, our measurements
of isomerase activity from healthy and affected animal lysates argue that TPI dimer integrity is
a stronger determinant of behavioral dysfunction. Still, this could indicate that reduced TPI
activity is corollary to the disease or a contributing factor to an alternative pathogenic mecha-
nism. Previous studies have demonstrated that the redox state is altered in TPI deficient cells
and organisms [33,59,60]. The redox status in TPI deficiency is proposed to be altered by
abnormal flux through the pentose-phosphate pathway as well as potential accumulation of
advanced glycation end-products (AGEs) [16,20,33,59–61], and the accumulation of redox
damage in the nervous system is strongly linked with several neurodegenerative diseases [62–
64]. Interestingly, a study in yeast demonstrated differences in redox responses between the
E104D and I170V mutations [16]; these results could imply different modes of pathogenesis
that are dependent on the conformational and catalytic states of TPI.
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hTPIΔcat predicted heterodimers
One unresolved aspect of this study was the inability of dTPIΔcat to fully complement the
behavioral defects of dTPIG74E. Co-IP experiments suggested that complementation correlated
with an inability of dimer-interface mutants to form heterodimers with dTPIΔcat (Fig 6). These
data would imply that dTPIG74E may be exhibiting a dominant negative effect as a heterodimer,
but this conclusion was inconsistent with our genetic analyses of dTPIWT/dTPIG74E animals
(Fig 4). To investigate whether TPIG74E may be interacting differently with TPIWT than with
TPIΔcat, we purified, crystallized, and determined the structure of hTPIΔcat at 1.7Å resolution.
While the hTPIK13M substitution (hTPIΔcat) resulted in multiple rearrangements that mimic
the open or non-catalytic TPI conformation, the dimeric interface remained essentially
unchanged, including the peptide backbone of Loop3 and sidechain positions hT75, hG76, and
hM82 (Fig 5). To address how hTPIT75R and hTPIG76E substitutions may influence the dimer
interface, we generated models of heterodimers in which one subunit contained either hT75R,
hG76E, or both hT75R and hG76E substitutions, while the other monomer remained unal-
tered. Models were made using either wild-type TPI hTPIWT (PDB: 4POC) or the hTPIΔcat
(PDB: 4ZVJ) as the structural template, and subjected to analysis by RosettaBackrub [65].
Briefly, Rosetta scores are predictions of the most energetically stable conformations with
higher scores indicating less favorable positioning of the model. The algorithm was run 50
times for each mutation to be modeled. Of these 50 simulations, the lowest scores of hTPIΔcat::
hTPIT75R and hTPIΔcat::hTPIG76E were selected and shown (Fig 9A and 9B), while the modeled
structures whose Rosetta scores fell within the best 10% of its respective ensemble were col-
lected for analysis (Fig 9C).
Modeling the hTPIT75R and hTPIG76E substitutions as homodimers or heterodimers with
the hTPIWT structure produced high Rosetta scores, predicting poor energetic favorability (Fig
9C) in agreement with our gel filtration experiments (S2 Fig). To examine TPIΔcat heterodimers
we used the new hTPIΔcat structure to model hTPIΔcat::hTPIT75R and hTPIΔcat::hTPIG76E. These
experiments predicted a high Rosetta score for hTPIΔcat::hTPIT75R and a very low one for
hTPIΔcat::hTPIG76E, corroborating the results of our animal lysate coIP experiments and sug-
gesting the simulated heterodimers may accurately represent the conformations of these
molecules.
The hTPIΔcat::hTPIT75R heterodimer with the lowest Rosetta score suggests the hR75 residue
may orient toward the catalytic pocket of hTPIΔcat, lining the floor of the substrate-binding
pocket through the displacement of hE165 and hK13M (Fig 9A). This orientation of hR75 into
the catalytic pocket is similar to that previously described by Wierenga and colleagues [28].
The hTPIΔcat::hTPIG76E heterodimer with the lowest Rosetta score suggests that hE76 finds a
stable position in the dimer interface through the displacement of hE104 and hR98, possibly
via coordination of the terminal amide of hN65 (Fig 9B). Interestingly, perturbation of hE104
has been shown to significantly alter the TPI dimer interface and elicits TPI deficiency in
humans through a conservative hTPIE104D substitution [15]. These modeling predictions sug-
gest that the character of the hTPIΔcat::hTPIG76E dimer interface is drastically altered relative to
hTPIΔcat homodimers.
Triosephosphate isomerase deficiency neuropathogenesis
Drosophila TPI deficiency neurologic dysfunction is characterized by impaired vesicle dynam-
ics at the neuronal synapse, a defect we believe is likely conserved in human patients. The key
to deciphering this pathogenic mechanism was the behavioral severity of the newly generated
TPI dimer interface mutants. The dTPIT73R allele exhibited temperature-dependent paralysis at
a mean time of approximately 27 sec., an acute behavior that is rare and highly enriched for
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synaptic or conductance defective mutants. Only a handful of Drosophilamutant alleles have
been identified with rapid temperature-dependent paralysis, including those of voltage-gated
Na+, K+, and Ca2+ channels (para, sei, cac) [66–68], the sodium-potassium exchanging ATPase
(ATPα) [69], and components of vesicle fusion and recycling (N-ethylmaleimide sensitive fac-
tor–dNSF1, dynamin–Shi) [70,71]; and after noting these phenotypic similarities we broadly
examined synaptic function. Stimulation was conducted using high [K+] bath applications,
thereby bypassing the participation of Na+ and K+ channels. The dTPIT73R mutants were char-
acterized by normal endocytosis during acute stimulations (15 and 30 sec.) but exhibited a dra-
matic reduction after 60 sec. of stimulation (Fig 7A), suggesting a time/excitation dependent
phenotype. Further, complementation with the dTPIΔcat allele significantly increased the tem-
perature-dependent FM1-43 loading at these terminals (Fig 7B and 7D), similar to its comple-
mentation of adult thermal stress-induced paralysis. Finally, measurements of vesicle
Fig 9. hTPIΔcat models predict that hTPIΔcat::hTPIG76E heterodimerization alters the TPI dimer
interface. (A) The R75 side chain may insert itself into the active site in the context of a hTPIΔcat::hTPIT75R
heterodimer. Shown is a superposition of hTPIWT (grey), hTPIΔcat (blue), and hTPIΔcat::hTPIT75R (green)
obtained from Rosetta Backrub modeling. Loop3, containing T75R and G76E, is indicated in tan. For clarity,
the mainchain of hTPIΔcat::hTPIT75R has been omitted. (B) Repositioning of E104 and R98 side chains assists
the dimer interface to accommodate the G76E substitution in Rosetta modeling. Superposition of hTPIΔcat
structure (blue) with the hTPIΔcat::hTPIG76E model (green). In both structures, Loop 3 is shown in tan and
selected active site pocket residues are indicated. (C) Modeling the effect of T75R and G76E substitutions in
the context of hTPIWT and hTPIΔcat structures. Normalized scores for the best 10% of 50 simulations were
averaged for each experimental structure with the indicated computational substitution. Higher scores
indicate a resulting model that is less favorable using the Rosetta energy function.
doi:10.1371/journal.pgen.1005941.g009
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exocytosis at these elevated temperatures did not indicate an exocytic defect (Fig 7E and 7F).
We were unable to detect terminal signal above background after 60 sec. of unloading, so we
cannot unequivocally define the nature of the vesicular dysfunction, but the data suggest it is
likely due to impaired endocytosis.
The observed synaptic defect provides insight into why the majority of human patients pres-
ent with TPI mutations affecting the dimer interface. First, all substitutions that disrupt the
dimer interface have been shown to destabilize the enzyme in vitro [28,29,55]. This destabiliza-
tion is likely responsible for the reduced cellular TPI found in patient samples, and our work
with the dTPIM80T, dTPIT73R, and dTPIG74Emutants provide additional evidence that dimer
interface substitutions reduce TPI levels in vivo (Fig 3A and 3B). Secondly, the cellular deple-
tion of dTPIM80T has been shown to be mediated by heat shock protein sequestration and pro-
teasomal degradation [34]. If chaperones sequestered and degraded these misfolded or
unstable proteins, this would likely prevent the distribution and maintenance of TPI at specific
subcellular locales. Recent work has shown that the anterograde transport of globular/soluble
proteins to the terminals is a slow process, moving at a rate of approximately 0.008–0.01μm/
sec [72]. To put this in the context of the Drosophila nervous system, the length of the relatively
short larval motor axon innervating muscle 4 of segment A3 has been measured to be ~220μm
[73]. Based on these approximations, one could estimate that it would take ~6 hrs for TPI
translated in the soma to be transported to the axonal terminal. In this way, substitutions that
affect protein stability would likely result in improper localization or sequestration of TPI dur-
ing distal transport, ultimately depleting TPI at the synapse. This proposal is also consistent
with the inability of RNAi knockdown to recapitulate Drosophila TPI deficiency behavioral
phenotypes, as RNAi alters mRNA transcript levels rather than enzyme conformation or stabil-
ity. RNAi knockdown of TPIWT would reduce, but still allow the transport and stable accumu-
lation of TPIWT at the synaptic terminal.
Two other Drosophila glycolytic mutants, aldolase and phosphoglycerate kinase, have been
shown to exhibit temperature-dependent paralysis though with longer onsets [74,75]. The
phosphoglycerate kinase mutant was shown to exhibit synaptic dysfunction, and the authors
asserted that an inhibition of vesicle recycling was likely the cause of the functional defect [75].
In both cases, the animals were found to have depletions in lysate ATP [74,75]. It is attractive
to speculate that all three of these glycolytic mutants may suggest a pivotal role for glycolysis
within synaptic vesicular dynamics, and indeed, recent measurements of ATP consumption in
the synapse suggest that glycolytic ATP is the primary substrate used to support synaptic func-
tion [76,77]. However, the role of glycolytic proteins and their putative energetic importance at
the synapse is controversial. Many research groups assert the preeminent utilization of mito-
chondrial ATP at these sites [78–81], while the lactate shuttle hypothesis largely circumvents a
role for neuronal glycolysis [82,83]. Further, the absence of a correlation between TPI catalytic
activity and behavioral phenotypes suggests that the enzyme may be complexing with another
molecule to facilitate synaptic vesicle cycling.
How the dimerization or integrity of the TPI dimer interface impacts synaptic vesicle
dynamics remains a mystery, though one candidate for a molecular complex is the actin-regu-
latory protein cofilin. In Drosophila, cofilin (twinstar) and twinfilinmutants have been demon-
strated to elicit functional and developmental neurologic defects [84–86], and actin-regulatory
proteins such as cofilin, actin-depolymerizing protein (ADP), and twinfilin are known to influ-
ence synaptic vesicle dynamics [85,87,88]. Recently, cofilin was found to bind to TPI in both its
inactive and active forms [89]. The precise binding site between cofilin and TPI is unknown,
though with its mixture of charged and hydrophobic pockets, the TPI dimer interface may pro-
vide a suitable site for this interaction. Additional studies will be needed to specifically delineate
the role of TPI in the synapse.
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In conclusion, to our knowledge this work is the first to highlight a critical role for TPI in
the cycling of vesicles at the synapse, with behavioral correlates similar to the inactivation of
vesicle fusion/recycling proteins. These observations help clarify the neurologic symptoms seen
in patients and will direct future therapeutic strategies. The findings of this study will guide
future investigations regarding the contribution of TPI localization and function to synaptic
vesicle dynamics, and ultimately how these properties are perturbed in TPI deficiency.
Materials and Methods
Animal strains
The ViennaDrosophila RNAi Center (VDRC) line used for knockdown experiments was stock
#25644 [37]; experiments were also conducted with #25643 with similar results. Thew;actin-GAL4,
UAS-GAL4; animals were generated by recombining the second chromosomes of theDrosophila
Genetic Resource Center (DGRC) stock y1 w1118; P(w+mC = UAS-Gal4.H)12B and Bloomington
Stock Center stock y1w; P(Act5C-GAL4)25FO1/CyO,y+; recombinants were screened molecularly
and balanced in a w1118 background. The following TPI alleles in this study were generated using
the GE system: dTPIWT, hTPIWT, dTPIWT-CFP, dTPIM80T, hTPIM82T, dTPIT73R, dTPIT73R-CFP,
dTPIG74E, dTPIG74E-CFP, dTPIT73R,G74E, dTPIΔcat, and dTPIΔcat-CFP. The development of the GE sys-
tem and the production of the dTPIWT, dTPIM80T, dTPIΔcat, and dTPIΔcat-CFP alleles were initially
described elsewhere [25]. Briefly, GE involves the replacement of the TPI gene locus with a phiC31
integration site through homologous recombination. The phiC31 integration system allows nearly
seamless integration of complementary vector constructs directly into the TPI gene locus to main-
tain endogenous spatial and temporal regulation. The TPInull allele used in S1 Fig was generated
previously, formerly known as TPIJS10 [19]. RNAi experiments used the TPIM80T allele formerly
known as TPIsgk [19], due to similarities with the UAS-RNAi and GAL4 genetic backgrounds.
This study uses the established nomenclature for TPI, assuming the start methionine is
removed following translation [13]; all residue numbering in this study uses the same conven-
tion. An alignment is included for clarification (Fig 1A). All animal populations assessed were
approximately equivalent mixtures of males and females.
Mutagenesis and genomic engineering
Site directed mutagenesis was performed using the QuikChange Lightening Site-Directed
Mutagenesis Kit (Agilent Technologies). Mutagenesis primers were generated (Integrated
DNA Technologies) to introduce a Thr-to-Arg codon change at position 73, and a Gly-to-Glu
change at position 74 –both separately and together for the purpose of creating the double-
mutant. Mutagenesis was performed on the previously published pGE-attBTPI+ plasmid [25]
and confirmed by sequencing. Once the constructs were generated, TPI GE was performed
using previously published methods [25,90,91]. Briefly, the PGX-TPI founder animals were
mated to vasa-phiC31ZH-2A animals expressing the integrase on the X chromosome and their
progeny injected with pGE-attBTPI constructs. Integration events were identified via the w+
phenotype and verified molecularly.
Human TPI enzyme purification
Human TPI enzyme was purified as outlined previously [18].
Dynamic Light Scattering
DLS measurements were taken using a DynaPro Plate reader (Wyatt Technology) equipped
with a temperature control unit. Purified BSA (Sigma Aldrich), hTPI+, and hTPIM80T were
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diluted to concentrations of 3.75 μM, 15 μM and 30 μM in 100 mM triethanolamine (TEA);
pH 7.6. Three 75 μl aliquots were loaded onto a 384-well microplate and read at 37°C. Ten
measurements were taken per sample and Dynamics V6 software (Wyatt Technology) was
used to process the scattering data, generating autocorrelation functions. Autocorrelation func-
tions were then analyzed to obtain the hydrodynamic radii. Student’s T test was used to com-
pare samples. DLS experiments were performed three times.
Gel filtration chromatography
Gel filtration was performed as outlined previously [26]. Purified TPI samples were diluted to
15 μM in mobile phase, 100 μl were injected in triplicate, and their elution monitored at 280
nm. Experiments were performed three times. Chromatography traces were collected and ana-
lyzed using EZStart 7.3 (Shimadzu) to quantify the relative monomer and dimer populations.
Curve integration data were compared using Student’s T test.
TPI enzyme assays
Isomerase activity was determined using an NADH-linked assay as previously detailed [25,92].
Lysates were diluted to 0.1 μg/μl in 100 mM TEA pH 7.6 + inhibitors and enzyme activity was
assessed. Reaction assays were performed in triplicate using 80 μl mixtures composed of 0.5
mMNADH, 0.752 mMGAP, 1 unit glycerol-3-phosphate dehydrogenase and 1 μg of lysate
protein in 100 mM TEA; pH 7.6. Consumption of NADH was monitored at 340 nm and 25°C
using a SpectraMax Plus 384 microplate reader (Molecular Devices). All reactions were per-
formed at least three times. Reaction components were purchased from Sigma-Aldrich.
Enzyme activity curves were normalized to reactions performed without GAP. A one-way
ANOVA was performed to assess variance, and data sets were compared using Tukey’s post-
hoc analysis.
Behavioral testing and lifespan analysis
Mechanical stress sensitivity was examined on Day 1 by vortexing the animals in a standard
media vial for 20 seconds and measuring time to recovery, similar to [93]. Briefly, recovery is
defined as two purposeful WT movements including righting, grooming, climbing, or walking.
Thermal stress sensitivity was assessed on Day 2 by acutely shifting animals to 38°C and mea-
suring time to paralysis, as previously described [24,69]. In these assays, the animals typically
seized and either flipped over onto their backs or fell sideways with no successive coordinated
movements, i.e. righting, climbing, walking, grooming. Behavioral responses were capped at
360 and 600 seconds where indicated and reported as 360 and 600 sec. Animal lifespan deter-
minations were performed at 25°C as previously described [69]. All assays used approximately
equivalent numbers of males and females. One-way ANOVAs were performed with Tukey's
post-hoc analysis to compare behavior, and lifespans were assessed with Log-rank (Mantel–
Cox) survival tests.
Immunoblots
Animals were collected and aged 1–2 days at room temperature. Ten fly heads were obtained
in triplicate from each genotype and processed as described previously [34]. Blots were incu-
bated with anti-TPI (1:5000; rabbit polyclonal FL-249; Santa Cruz Biotechnology), anti-ATPal-
pha (1:10,000; mouse monoclonal alpha5; Developmental Studies Hybridoma Bank), or anti-β
tubulin (1: 6,000; rabbit polyclonal H-235; Santa Cruz Biotechnology). Densitometric analyses
of the scanned films were performed on unsaturated exposures using ImageJ software available
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from the National Institutes of Health. A one-way ANOVA was performed to assess variance
of TPI levels and data sets were compared using Tukey's post-hoc analysis.
Filter-trap dot blot
The filter-trap dot blot was modified from methods published previously [36]. Animals were
aged 1–2 days, collected and homogenized in 1X PBS (2.7 mM KCl, 137 mMNaCl, 2 mM
NaH2PO4, 10 mM Na2HPO4; pH 7.4) supplemented with cOmplete mini Protease Inhibitors
(Roche Diagnostics), and diluted to 1 μg/μl; wells were loaded as indicated. Samples were
diluted 1:2 in 1% SDS, 1X PBS, boiled for 5 min., and filtered through a cellulose acetate mem-
brane (Whatman, 0.2μm pore) using a 96-well vacuum dot blot apparatus. Positive controls
were collected from PC12 cells transfected with a construct expressing huntingtin “exon1”
bearing a stretch of 97 glutamines and C-terminally tagged with EGFP. The membrane was
washed four times with 1% SDS-PBS, blocked with Odyssey Blocking Buffer (LiCor), and pri-
mary antibodies applied in Odyssey Blocking Buffer. Blots were incubated with anti-TPI (1:
5000) and anti-GFP (1: 5000; rabbit polyclonal; FL; Santa Cruz Biotechnology). The mem-
branes were then washed and incubated with the secondary antibody IRDye 800-conjugated
goat anti-rabbit (LiCor) at 1: 20,000 in Odyssey Blocking Buffer. Direct-to-scanner detection
and blot visualization were performed using a LiCor Odyssey scanner. Filter-trap experiments
were performed twice.
Coimmunoprecipitation experiments
Coimmunoprecipitation was performed using the Pierce Co-Immunoprecipitation Kit
(Thermo Scientific) as per manufacturer’s instructions. Lysates were generated by mechanically
homogenizing 50 animals in 0.5 ml of IP Lysis buffer (25 mM Tris, 150 mM NaCl, 1 mM
EDTA, 1% NP-40, 5% glycerol; pH 7.4) supplemented with cOmplete mini Protease Inhibitors.
After homogenization, lysates were frozen in liquid nitrogen, thawed, then centrifuged twice at
5,000 g to pellet exoskeletal debris. Supernatants were collected and diluted to 1 μg/μl, and
400 μg were loaded onto 25 μl of gel pre-coupled with 10 μg of anti-GFP. A negative control
was performed using uncoupled gel and dTPI+/dTPIΔcat lysate. Samples were incubated over-
night at 4°C and washed ten times with IP Lysis buffer at 4°C. Beads were eluted by boiling
with 70 μl of 2X SDS–PAGE sample buffer, separated via SDS-PAGE, immunoblotted, and
analyzed as outlined above. Coimmunoprecipitations were performed three times.
FM1-43 imaging experiments
Images were taken with an Olympus BX51WI fluorescence microscope with Till Photonics
Polychrome V monochromator excitation, and Hamamatsu C4742-95 digital camera. Hetero-
zygous TPIT73R larvae were maintained over TM6B, and Tb+ 3rd-instar larvae selected for anal-
ysis. Dissection and preparation of larval NMJs were performed as described previously [46].
FM1-43FX dye [Molecular Probes, Invitrogen] loading was performed as previously detailed
[47]. Briefly, animals were dissected in ice cold 0 mM Ca2+ HL-3 with 0.5 mM EGTA, motor
neurons severed, and the preps heated to room temperature or 38°C over the course of 3 min.
Bath temperature was monitored throughout the experiments with a microthermal probe to
ensure consistency [Fisher Scientific]. Loading experiments were performed with room tem-
perature or 38°C preheated 90 mM KCl, 1.5 mM CaCl2 HL-3 supplemented with 4 μM FM1-
43FX, and preparations were washed quickly and thoroughly during the experiments to avoid
Ca2+ chelation. After loading, preparations were washed with 15 ml of 0mM Ca2+ HL-3 with
0.5 mM EGTA at room temperature for 10 min. Unloading experiments were performed as fol-
lows: preparations were loaded for 3 min at room temperature; washed with 15 ml of 0mM Ca2
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+ HL-3 with 0.5 mM EGTA at room temperature; imaged; washed with 38°C 0 mM Ca2+ HL-3;
heated to 38°C over 3 min.; unloaded using 38°C 90 mM KCl, 1.5 mM CaCl2 HL-3 for 30 sec.;
and the same synapse was imaged again.
Preparations were imaged with a water immersion 60X objective, using 450 nm excitation
and a 500 nm longpass filter [Chroma Technology]. Simple PCI imaging software was used for
acquisition and ImageJ for analysis. Two NMJs from muscles 6/7 were assessed per animal,
one from segment A2 and A3. Six animals were assessed per genotype per time point for a total
of 12 NMJs per experimental condition. After acquisition, images were relabeled by an inde-
pendent researcher and blinded analysis was performed on the raw images. Boutons were out-
lined and intensity measured, with background subtracted from adjacent tissue. Pair-wise
analyses were performed using a two-tailed Student’s t test, while comparisons among multiple
experimental conditions were performed using a one-way Analysis of Variance (ANOVA)
with Tukey’s post-hoc analysis.
NMJmorphological analyses
For NMJ morphological analyses, 3rd-instar larvae were collected and dissected as detailed
above without transection of the descending motor neurons. Preparations were fixed in 3.5%
paraformaldehyde HL-3, permeabilized with 0.1% Triton X-100 in 1X PBS (PBST), and
blocked with 0.2% BSA in PBST (PBSTB) for 2 hrs at room temperature. Preps were washed
and incubated with goat anti-HRP [Jackson Laboratories] at 1: 200 in PBSTB for 2 hrs at room
temperature. Primary antibodies were removed, washed in PBSTB, and incubated with Cy3-la-
beled donkey anti-goat in PBSTB at 1: 400 for 1.5 hrs at room temperature. Preps were washed,
mounted in VectaShield [Vector Laboratories], and imaged within three days. Images were
acquired with an Olympus confocal FV1000 microscope, using a 559 nm excitation laser. Z
stacks of segment A2 of muscle 6/7 were taken using 1 μm steps. The Z stacks were merged
using Olympus FV1000 Fluoview Viewer, and morphology determined. Ten animals were
assessed per genotype, one NMJ per animal, for a total of ten NMJs per experimental condition.
Boutons were defined as varicosities at least 2 μm in diameter, and branches defined as exten-
sions containing at least 2 boutons. Images were relabeled by an independent researcher for
blinded analysis. Variance within the data set was examined using a one-way ANOVA, with
comparisons made using Tukey’s post hoc test.
Image analysis and presentation
All image quantification was performed on raw image files acquired below saturation. Repre-
sentative images were selected on the basis of raw image measurements, and post-acquisition
processing was performed uniformly with grouped images in parallel using ImageJ; in agree-
ment with published guidelines [94].
Crystallization and structure determination of hTPIΔcat
Recombinant hTPIΔcat containing the K13M substitution was expressed and purified as previ-
ously described [18] using affinity, anion exchange, and size exclusion chromatography. Puri-
fied protein was dialyzed into a buffer containing [20 mM Tris pH 8.8, 25 mM NaCl, 2.0%
glycerol and 1 mM β–mercaptoethanol], and concentrated to 6 mg/ml prior to crystallization.
Crystals of TPIΔcat were obtained using the vapor diffusion method with sitting drops contain-
ing 1 μl of protein and 2 μl of well solution [28–34% PEG2000 MME, 50 mM KBr]. Initial crys-
tals grew within 3 days and were improved by successive rounds of microseeding. Crystals
were cryoprotected in 40% PEG 2000MME, 20% glycerol, 50 mM KBr, prior to flash freezing
in liquid nitrogen.
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Data collection was performed at the National Synchrotron Light Source at beamline X25
and using a Pilutas 6M detector. Diffraction data was integrated, scaled, and merged using
HKL2000 [95]. hTPIΔcat crystals belong to space group P212121 and contain a dimer in the
asymmetric unit. Initial phases were estimated for hTPIΔcat via molecular replacement using a
previously determined structure of wild-type as our search model [18]. Model bias was reduced
through simulated annealing and the model was further improved by manual model building
combined with positional and anisotropic B-factor refinement within Phenix [96]. Model qual-
ity was validated using MolProbity [97]. Figs were generated using PyMOL (PyMOLMolecular
Graphics System, Schrödinger, LLC). Coordinates and structure factors for hTPIΔcat have been
deposited within the Protein Databank under accession code 4ZVJ.
Molecular modeling of dimer interface substitutions
The effect of hT75R and hG76E substitutions were modeled onto hTPIΔcat or hTPIWT struc-
tural templates using the RosettaBackrub analysis as implemented within the RosettaBackrub
server [98]. For all predictions, Rosetta version 3.1 was used as the algorithm with a backrub
radius of 15 Å to ensure that perturbations extending away from the site of the substitution
could be sampled. An ensemble of 50 structures was predicted for each TPI model, and their
reported Rosetta scores normalized to the starting template. Structures whose Rosetta scores
were in the most favorable 10% of the ensemble were used in Fig 9D.
TPI nomenclature
Triosephosphate isomerase research has been split between those studying the enzymatic and
structural properties of the protein, and those studying its role in disease. Researchers focusing
on the pathology of TPI deficiency typically use the abbreviation “TPI”, whereas enzymologists
and structural biologists used the abbreviation “TIM”. The aim of this study was to determine
the molecular mechanism of a disease mutation, and as such we have used the abbreviation
“TPI”.
Supporting Information
S1 Fig. hTPIM82T/null phenocopies the behavioral and longevity effects of dTPIM80T/null. (A)
dTPIM80T/null and hTPIM82T/null elicit significant delays in time to recovery from mechanical
stress at Day 3, (B) time to paralysis after thermal stress at Day 4, and (C) longevity compared
to dTPIWT/null and hTPIWT/null, respectively. All animals were reared at 25°C, and thermal stress
paralysis times at 600 sec. represent wild type behavior; the assay was stopped at 10 min. as pre-
viously outlined for hTPI alleles [18]. n20 for behavior and n70 for lifespans. The TPInull
and hTPIWT alleles were generated previously [18,19], with TPInull representing a deletion of
two of three constitutive TPI exons. Comparisons were made with Student’s T test, and life-
spans by a Log-rank (Mantel-Cox) survival test,  indicates p<0.05 and  p<0.001.
(EPS)
S2 Fig. TPI dimer interface substitutions impair enzyme dimerization. Purified hTPIΔcat,
hTPIT75R, hTPIG76E, and hTPIT75R,G76E were examined via size-exclusion chromatography for
monomer and dimer content. Each dimer interface substitution displays a significant increase
in monomeric TPI relative to the enzyme dimer (n3). hTPIWT and hTPIΔcat intermittently
displayed some monomer species, and were prepared and analyzed in parallel with the dimer
mutations. Comparisons were made with a One-way ANOVA using Tukey’s post hoc test, 
indicates p<0.001.
(EPS)
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S3 Fig. RNAi knockdown of TPIWT fails to recapitulate dTPIM80T phenotypes. (A) TPI pro-
tein levels were knocked down ubiquitously and confirmed in thorax and (B) head tissues
(n3) with quantification and representative images. (C) Knockdown animals failed to display
typical mechanical-stress dependent paralysis at Day 5 aged at 25°C (n15). TPIWT animals
are w1118;; controls while the TPIM80T allele used was formerly known as TPIsgk [19]. Compari-
sons were made with a One-way ANOVA using Tukey’s post hoc test, ns indicates no signifi-
cance,  p<0.01, and  p<0.001 relative to WT. Experiments shown are derived from
knockdown using VDRC line #25644; VDRC #25643 was also examined, with similar results.
(EPS)
S4 Fig. TPIT73R,G74E behavioral dysfunction and longevity. (A) dTPIT73R,G74E is characterized
by severe mechanical and (B) thermal stress sensitivity, which respond positively to comple-
mentation by dTPIΔcat. Thermal stress paralysis times at 360 sec. represent wild type behavior;
the assay was stopped at 6 min. (C) TPIT73R,G74E exhibits reduced lysate catalytic activity com-
pared to WT. (D) TPIΔcat fails to complement TPIT73R,G74E longevity. n30 for all behavior,
n80 for all lifespans. Comparisons were made with a One-way ANOVA using Tukey’s post
hoc test, and lifespans by a Log-rank (Mantel-Cox) survival test, ns indicates no significance, 
p<0.01,  p<0.001.
(EPS)
S5 Fig. Lysate isomerase activity does not predict disease presence or severity. (A) Lysate
activity is indicated and (B) expanded as per the dashed box. Comparisons were made with a
One-way ANOVA using Tukey’s post hoc test, ns indicates no significant differences and 
p<0.001. Biological replicates are indicated.
(EPS)
S6 Fig. C-terminal CFP tags do not alter TPI dimer mutant neuropathology. C-terminal
CFP tags were added to dTPIT73R, dTPIG74E, and dTPIT73R,G74E. (A) Animals were crossed
with similar alleles lacking the CFP tag, and the resulting progeny retain the mechanical- and
(B) thermal-stress sensitivity. n>10. Thermal stress paralysis times at 360 sec. represent wild
type behavior; the assay was stopped at 6 min. Comparisons were made with a One-way
ANOVA using Tukey’s post hoc test,  indicates p<0.001. # indicates the animals did not
paralyze within 360 sec.
(EPS)
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